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Soluble methane monooxygenase (sMMO) belongs to a family of metalloproteins called 
bacterial multicomponent monooxygenases (BMMs), which contain carboxylate-bridged non-
heme diiron cores. These sMMO enzymes are of high interest because they utilize readily 
available molecular oxygen in their energy conversion of methane to methanol in the metabolic 
system of methanotrophic bacteria. Methane is abundant in natural gas, and if it can be converted 
to methanol, a liquid form, under mild conditions as in the enzyme, transportation of this energy 
source to remote areas will be safer and more convenient. Our research group has a long-term 
interest in developing small molecule synthetic analogs that can mimic both the structure and 
function of the active site of the hydroxylase component of sMMO (sMMOH). Unfortunately, no 
ligand system designed to date has been able to achieve this goal. In our further attempt, 
synthesis of a triptycene-based bis(benzimidazole) diester ligand L3 is discussed in this paper 
along with its coordination with iron(II) salt and an external carboxylate. Characterization of the 
diiron(II) complexes was achieved using UV-vis spectrophometric titrations, X-ray diffraction 
studies, Mössbauer spectroscopy, and IR spectroscopy. Preliminary oxygenation studies of the 
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Thousands of chemical reactions taking place in living cells at any given instant time are 
made possible by virtue of enzymes in the living organisms. Enzymes lower the energy barrier in 
metabolic processes and thus accelerate the rates of chemical reactions. Proteins containing 
metal centers at their active sites are called metalloenzymes. Their importance in 
transformations, such as nitrogen fixation,
1-4
  water splitting,
5
 and hydrogen production,
6
  has led 
to a tremendous surge of research interest aimed at studying metalloenzymes.  
Carboxylate-bridged Non-heme Diiron Proteins 
Among iron-containing proteins, an important class of metalloenzymes has carboxylate-
bridged non-heme diiron active sites.
8-13







 and bacterial multicomponent monooxygenases (BMMs).
16
 Although these 
metalloproteins perform different functions in nature, they share the same initiation step in their 
respective reaction mechanisms. This first step involves binding and/or activation of O2 at the 
diiron(II) active sites. In hemerythrin (Hr), the reversible coordination of dioxygen to a single 
iron site enables the O2 transport in marine invertebrates such as sipunculids, annelids, priapulids 
and brachiopods.
17,18
  In RNR-R2 and BMMs, dioxygen is consumed by the diiron(II) active 
sites in the catalytic cycle, forming Fe(III)/Fe(IV) intermediates that act as oxidases in chemical 
reactions.
19-23
 The intermediate in RNR-R2 is important in conversion of ribo- to 
deoxyribonucleotides while the C—H bond activation is performed by the intermediate in the 














Figure 1. Active site structures in the hydroxylase proteins of certain members of bacterial 
multicomponent monooxygenases (BMMs): a) soluble methane monooxygenase (sMMO); b) 
toluene/o-xylene monooxygenase (ToMO); c) phenol hydroxylase (PH). Their active site 
structures are analogous although the proteins perform different functions in nature. 
 
Soluble Methane Monooxygenase (sMMO) 
Of all the remarkable carboxylate-bridged non-heme diiron proteins, our laboratory has a 
long-term interest in studying bacterial multicomponent monooxygenases (BMMs).
16,24, 25
 They 
include soluble methane monooxygenase (sMMO),
16,24,26,27
 toluene/o-xylene monooxygenase 
(ToMO),
28,29
 phenol hydroxylase (PH),
28





 Despite their diverse functions, these proteins share similar active site structures, 
which include diiron(II) cores coordinated by terminal and bridging carboxylate ligands, water 
and/or OH groups, and two histidine residues (Figure 1). Among the BMM family members, 
soluble MMOs have been widely investigated because they can utilize earth-abundant molecular 




CH4 + O2 + H
+
 + NAD(P)H  CH3OH + NAD(P)
+
 + H2O  (1) 
 
This chemical reaction is significant because breaking the strong C—H bond in methane 
chemically (104 kcal/mol, the highest C—H bond energy among hydrocarbons) is very 
(a) (b) (c) 
7 
 
challenging. The ability of sMMO to selectively oxidize methane to methanol under ambient 
conditions is quite impressive. Understanding how the enzyme performs will demystify this 
marvelous natural phenomenon.   
Soluble MMO enzymes are typically found in the metabolic system of methanotrophic 
bacteria, which consume methane as their sole source of carbon and energy. Methane is 
generated from carbon dioxide by methanogenic bacteria under anaerobic conditions such as 
lakes, oceans, and wetlands. Since both methane and dioxygen are essential for methanotrophs, 
these bacteria thrive in the borderline region of the aerobic and anaerobic environments. 
Expression of sMMO is favored at low copper concentration in the environment whereas 
virtually all methanotrophic bacteria express a membrane-bound, particulate form of methane 
monooxygenase (pMMO). Although sMMO contains a non-heme diiron unit, recent studies on 
pMMO have revealed the presence of two distinct copper-containing active sites.
24
 The 
particulate form is unstable, difficult to purify, and capable of accommodating methane only. 
The soluble form, on the other hand, has been widely studied due to its high stability, ease of 
purification, and ability to oxidize a broad range of organic substrates such as saturated and 
unsaturated, linear, branched, and cyclic hydrocarbons; aromatic, heterocyclic, and chlorinated 
compounds; sulfides; and many others.
24
 This versatile function of soluble methane 
monoxygenase makes methanotrophs important in bioremediation of the environment.  Practical 
applications of the bacteria include purifying drinking water from chlorinated hydrocarbons and 
cleaning beaches that are contaminated with petroleum oil.
24
 
Catalytic Cycle of sMMOH 
Extensive studies of sMMO have led to the delineation of its structural and electronic 
properties to a large extent. As shown in Figure 2a, sMMO is composed of three components: the 
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hydroxylase (MMOH), the reductase (MMOR), and a regulatory protein (MMOB). Although all 
three components of sMMO play important roles in the catalytic cycle, MMOH alone is 
sufficient for both dioxygen activation and substrate hydroxylation.
24
 Figures 2b and 2c depict 
the diiron core structures of sMMOH in different oxidation states in the catalytic cycle.
33
 Both 
diiron coordination spheres contain oxygen rich environments with (i) four glutamate 
carboxylates, (ii) two hisidine N-donors with syn stereochemistry (on the same side) to the Fe-Fe 
vector, (iii) OH/H2O bridge(s), (iv) a water molecule, and (v) a carboxylate bridge in the 
orthogonal position to the diiron-dinitrogen coordination plane.  
 
Figure 2. a) Overall fold of the three components of sMMO
24 
: the reductase component 
(MMOR), the regulatory protein (MMOB) and the hydroxylase component (MMOH); b) Active 
site structure of sMMOH in its diiron(III) resting state; c) in its diiron(II) reduced state. In both 
states, the diiron core is coordinated by two histidine residues (nitrogen atoms shown in blue) 








The catalytic cycle of sMMO for dioxygen activation and methane hydroxylation is 
shown in Scheme 1. At the beginning of the cycle, the coordination core is in its resting 
diiron(III) state (Hox) (Figure 2b). Upon the gain of two electrons from MMOR, Hox gets reduced 
to a diiron(II) state (Hred), which readily reacts with dioxygen to form a diiron(III) peroxo 
intermediate. The peroxo adduct can further decay to a high-valent di(μ-oxo)diiron(IV) species 
called intermediate Q. Intermediate Q is responsible for the C—H bond activation in methane by 
abstracting the hydrogen atom via a radical mechanism. When H3C radical recombines with the 
OH/H2O ligand at the diiron core, methanol is extruded from the active site. Efficient catalysis is 




          




Biomimetic Modeling of the Active Site of sMMOH 
All the knowledge accumulated from the enzymology studies of sMMOH has inspired 
chemists to construct synthetic models that can faithfully replicate its active site structure and, 
more importantly, its catalytic activity. Small molecule synthetic modeling has been employed as 
a useful tool for chemists to further our understanding of the biological system.
34
 For instance, 
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by comparing the spectroscopic properties of the synthetic diiron complexes with those of the 
enzyme, the structural information of the transient state of the enzyme in the catalytic cycle can 
be elucidated to some extent.
33
 
There are two main approaches in synthetic modeling of the active sites of 
metalloenzymes.
35,36
 A biomimetic approach places an emphasis on faithfully replicating the 
geometry and coordination environment around the metallic core whereas a bio-inspired 
approach imposes less restriction on the identity and orientation of the coordinating ligands 
relative to the metal centers. The bio-inspired approach focuses more on simulating the function 
of the target metalloenzyme. Because biomimetic model compounds display structural 
characteristics of the active site of the metalloenzyme while reserving their potential implication 
on the catalytic activity of the target enzyme, the first approach is usually more favored in 
modeling studies for bioinorganic chemists. Biomimetic modeling of the active sites of 
metalloenzymes will not only enrich our knowledge of the structures and mechanistic functions 
of the enzymes but also advance our attempts to make functional catalysts. 
As described earlier, the catalytic cycle of sMMOH involves multiple enzyme 
components and various chemicals such as NADH, O2, methane, proton/water, etc. Modeling the 
structure and chemistry of the active site of sMMOH is certainly quite challenging. Over the past 
three decades, our group and several other research groups have developed many types of ligand 
systems that could construct diiron complexes with various similar properties to the sMMOH 
active site. The evolutional progress of this work has led to the attention of dinucleating ligand 
systems and syn N-donor character.
36
 In the past decade, our group has focused on the design and 
synthesis of a series of dinucleating ligands with several criteria that need to be addressed to best 
mimic the natural protein.
33
 (i) To be a good structural and functional mimic, the ligand needs to 
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provide an oxygen-rich environment with all donor arms approaching the diiron core at specific 
orientations. (ii) The ligand should allow carboxylates to bridge between the diiron centers. (iii) 
Steric effects in the ligand framework should be carefully tuned to obtain a dinucleating ligand 
platform.  Mononuclear iron species tend to form if the ligands are too bulky whereas undesired 
polynuclear clusters can be conceived if the framework does not have sufficient steric repulsion. 
(iv) Since oxygenation of sMMOH involves transient diiron(III) and (IV) intermediates, the 
synthetic models are expected to accommodate different oxidation states of the diiron core. In 
other words, the coordination sphere of the diiron(II) core should not be fully saturated or should 
have readily replaceable ligands such as water or organic solvent molecules. (vi) Flexibility of 
the model compound structure should also be taken into consideration as dioxygen activation can 
result in carboxylate shifts in the active site of sMMOH.   
Some Prior Ligand Designs for sMMOH 
Over the past three decades, much effort has been made in small molecule synthetic 
modeling of the active site structure of sMMOH. Although there has not yet been any model 
compound that can faithfully replicate both the structure and function of its active site, the 
information obtained from the different ligand systems has enriched our understanding of the 
enzyme and advanced our mimicking attempts.
36,37 
Some remarkable prior achievements are 




Failure of simple benzoates
41-43 
to mimic the carboxylate-bridged non-heme diiron core 
of sMMOH led to the investigation of better candidates with both high structural integrity and 
flexibility. Dicarboxylates were found to be promising dinucleating platforms that have bridging 
potential between the two metal centers. A good example is the doubly deprotonated form of m-
12 
 
xylenediamine bis(Kemp’s triacid imide) (XDK2-, Table 1).36,38,39 The preorganized nature of the 
ligand framework and a definite cleft formed by the two carboxylate units in XDK
2-
 afforded a 
carboxylate-bridged dinuclear complex [Fe
II
2(XDK)(μ-PhCyCO2)(PhCyCO2)(py)2] (1, where 
PhCy = 1-phenylcyclohexylcarboxylate and py = pyridine).
36,40
 The employment of a basic N-
donor (py) and a sterically hindered external carboxylate (PhCy) allowed 1 to maintain its 
dinuclear structure upon exposure to dioxygen and also form a stable peroxo intermediate at low 
temperature. Unfortunately, there was no conversion of the peroxo adduct to a di(μ-O) Q-
intermediate upon warming. This shortcoming could be attributed to the geometric restriction at 
















In the pursuit of better modeling platforms, reducing the steric constraints of the ligand 
framework was desired, and terphenylcarboxylates were discovered to be ideal building blocks. 





Bupy)2] (2A, Table 1) where Ar
Tol









Table 1. Some prior ligand designs in biomimetic modeling of the active site of sMMOH.
36
 













-Enables assembly of [Fe
III
2O] units 
thatcould not be accessed using 
simple carboxylates 
 
-Does not enforce dinuclearity 36, 40 
       
         
   
 







  -Forms diiron complexes in the 
presence of Fe(II) salts and an 
appropriate base 
 -The steric encumbrance of the 
2,6-aryl groups restricts access 
to the diiron core  
 
      
36,44 
       
     
-Stablilizes high-valent iron species  
 
-Does not prevent formation of 
polyiron species 
 
   
 
 
-Easy to synthesize 
    






-Enforces the syn stereochemistry 
of nitrogen donors relative to the 
Fe-Fe vector 
 
-Neutral oxygen donors, rather 
than anionic 36, 45 
      
 
      
-Quinoline ester group does not 
sufficiently stabilize the iron 
centers 
        
     
-Accommodates binding of 
external carboxylates to the diiron 
core 
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-Supports a carboxylate-bridged 
diiron(II) unit  
-Does not prevent formation of 
tetrairon species 
36, 46 
       
     
-Maintains a dinuclear core upon 
reaction with O2  
-Phenolate and imine donors are 
not biomimetic  
       
   
 
 
-Can be sterically tuned without 
obstructing access to the metal 
binding pocket 
    
   
 
     
   
6 
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! Forms stable tripo-
dal chelate with iron 
! N-donors similar to 
histidine residues 
! Easy to synthesize 
 
! Capping unit re-
stricts binding to the 
metal center 













! Contains biomimetic 
imidazole groups 
! Bidentate chelate 
allows assembly of 
asymmetric diiron 
unit with open sites 
! Easy to synthesize 
 
 















! Enables assembly of 
[Fe
III
2O] units that 
could not be ac-
cessed using simple 
carboxylates 
 
















! Supports a diiron 
core with open sites 
for substitution with 
external bases 
! Maintains a di-
nuclear structure 
upon reaction with 
dioxygen 
  
! Endo positioning of 
carboxylates may be 
too geometrically 
restrictive 



















! Supports an 
{Fe
II
2(OH)} core with 
an open metal bind-
ing site 
! Stabilizes an oxy-
genated adduct to 
the diiron center 
 



















! Does not prevent 
formation of polyiron 
clu ters 
! Difficult to prepare 
in gram quantities 
 
62-64 
* The donor atoms highlighted in red in the iron complexes (second column) are derived from the donor groups, also 
shown in red, of the featured ligand (first column).  
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nuclear structure 
upon reaction with 
dioxygen 
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{Fe
II
2(OH)} core with 
an open metal bind-
ing site 
! Stabilizes an oxy-
genated adduct to 
the diiron center 
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! Does not prevent 
forma ion of polyiron 
clusters 
! Difficult to prepare 
in gram quantities 
 
62-64 
* The donor atoms highlighted in red in the iron complexes (second column) are derived from the donor groups, also 
shown in red, of the featured ligand (first column).  
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Table 1. (Continued) 



























! Forms diiron com-
plexes in the pres-
ence of Fe(II) salts 
and an appropriate 
base 
! Stabilizes high-
valent iron species 
! Easy to synthesize 
 




access to the 
diiron core 
! Does not pre-


















! Conta s a “masked 
carboxylate” to 
bridge two metal 
centers 
! Stabilizes diiron 






















































! Enforces the syn 
stereochemistry of 
nitrogen donors 
relative to the Fe–Fe 
vector 
! Accommodates 
binding of external 
carboxylates to the 
diiron core 
 
! Neutral oxygen 
donors, rather 
than anionic 
! Quinoline ester 
group does not 
sufficiently stabi-

















! Contains a bridging 
carboxylate unit in 
addition to two adja-
cent amine groups 
 
! Not sufficiently 
pre-organized, 
could not metal-
late with iron 









* The donor atoms highlighted in red in the iron complexes (second column) are derived from the donor groups, also 
shown in red, of the featured ligand (first column).  
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* The donor atoms highlighted in red in the iron complexes (second column) are derived from the donor groups, also 
shown in red, of the featured ligand (first column).  
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Table 1. (Continued) 
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* The donor atoms highlighted in red in the iron complexes (second column) are derived from the donor groups, also 
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 Reaction of 2A with O2 irreversibly 
gave a deep green intermediate, comprised of equimolar amounts of a diiron(II,III) (3) and a  
diiron(III,IV) (4) species.  Scheme 2 shows the proposed mechanism of the formation of the two 
intermediate forms. Worthy of notice is the fact that 2A represents the first synthetic model 
compound, which upon oxygenation afforded an iron(IV) intermediate as in the enzymatic 
mechanism. Despite these advances, the oxygenated intermediates exhibited low reactivity with  
hydrocarbons because the intermediates participated in intermolecular electron transfer reactions 
and were rapidly deactivated.
36,44
 
Syn N-Donor Ligands 
 One of the main challenges in biomimetic modeling of the active site structure of 
sMMOH is to reproduce the syn stereochemistry of the nitrogen donors from the histidine 
residues relative to the diiron vector.
33
 A continued search for potential syn N-donor ligands led 
to the investigation of the iron chemistry of 1,2-bis(3-ethynyl-8-carboxylatequinoline)-4,5-
diethynylbenzene ethyl ester (Et2BCQEBEt, Table 1).
36,45











(5), a diiron(II) complex with 
three bridging carboxylates and syn arrangement of N-donors from quinoline moieties. Although 
5 closely mimicked the diiron core of sMMOH, the neutral oxygen donors from ethyl esters were 




 Macrocyclic ligands show an unprecedented property in our efforts to develop 
sophisticated but well-defined diiron complexes that can accurately replicate the coordination 
environment in our targeted metalloenzyme. One such macrocyclic compound is H2PIM, 





 Upon the reaction of H2PIM with [Fe2(Mes)4] (Mes = 2,4,6-
trimethylphenyl) and terphenyl carboxylic acid, Ar
Tol







(6) was obtained (Table 1).
36,46
 X-ray single crystal analysis of 6 revealed its 
ability to closely resemble the sMMOHred active site motif based on the characteristics such as 
the syn N-donor conformation and an asymmetric μ-η1,η1 and μ-η1,η2 binding mode of 
carboxylates. Exposure of 6 to dioxygen afforded a mixture of (μ-oxo)diiron(III) [FeIII2(μ-
O)(Ar
Tol










CO2)2] species when treated with excess water. Formation of this polynuclear 
compound may be prevented by modifying the PIM
2-
 ligand platform with bulkier groups and 
employing less sterically demanding external carboxylates. Although phenolate and imine 
groups in PIM
2-
 are not biologically relevant donors in sMMOH and are susceptible to either 
oxidation or hydrolysis, this ligand design is noteworthy because of its syn N-donors and anionic 
O-donors as well as its ability to accommodate multiple oxidation states and external carboxylate 
bridges between the diiron centers.  
Proposed Ligand Design  
As mentioned above, our goal is to design novel dinucleating pre-organized ligand 
frameworks that contain a hydrophobic pocket and a syn N-donor character to the diiron vector 
in an oxygen-rich environment. In our further attempt to fulfill the described requirements, Dr. 
Yang Li, my mentor, has proposed the design of a triptycene-based bis(benzoxazole) ligand with 
three carboxylic acids (9, Figure 3a). In contrast to the external carboxylate bridges in all prior 
synthetic models, an internal carboxylate bridge is incorporated in the ligand design to examine 
its unique property in tuning the stability and reactivity of the diiron core. The two carboxylic 
16 
 
acids on the benzimidazole rings are intended to represent the two terminal glutamic acids while 
the rigid biphenyl hanging down from the third wing of the triptycene backbone is designed to 
deliver an internal carboxylic bridge close enough to the potential diiron core. The expected 
diiron complex derived from 9 is illustrated in its SPARTAN model (Figure 3b). 
                 
Figure 3. a) Initial proposed ligand design, triptycene-based bis(benzoxazole) triacid ligand 9 to 
mimic the active site structure of sMMOH. b) A SPARTAN model of the expected diiron 
complex derived from 9. Each iron site is coordinated by a benzoxazole nitrogen atom and a 
carboxylic acid oxygen atom. The diiron core is linked by an internal carboxylate bridge and two 
hydroxo bridges between the diiron centers, as in the enzyme.  
 
Because the construction of this three-arm ligand 9 is synthetically challenging, and the 
coordination behavior of the two N,O-donor arms with iron is unknown, exploring the iron 
chemistry of the two-armed benzoxazole diester ligand L1 (Figure 5)
47
  became our first priority. 
The synthesis of L1 has been accomplished in 11 steps. Coordination of L1 with iron(II) salt 
achieved a dinuclear iron complex [Fe2L1(-OH)(-O2CAr
Tol
)(OTf)2] (Figure 4a), which closely 
mimics the core of sMMOH. Furthermore, its diacid analog, H2L2
Ph4
 (Figure 4b) with sterically 
encumbered group on the ortho-position of the carboxylic acid was prepared. Unexpectedly, 
treatment of this diacid ligand, H2L2
Ph4






)2(μ3-O)(μ-O2CCPh3)2(H2O)3](OTf)2, revealing the inert nature of 
the benzoxazole N-donors in the triiron complex. 








Figure 4. a) X-ray crystal structure of [Fe2L1(-OH)(-O2CAr
Tol
)(OTf)2] 24; b) SPARTAN 
model of the triptycene-based bis(benzoxazole) diacid ligand, H2L2
Ph4
, with sterically hindered 
groups on the ortho-position of the carboxylic acids. 
 
This weak electron donating nature of the nitrogen to the metal center is rationalized by 
the low basicity of the benzoxazole nitrogen (pKb = 13.2). In contrast, the pKb of a 
benzimidazole nitrogen (pKb = 8.2) is lower than that of a benzoxazole nitrogen by five orders of 
magnitude (Figure 5). The close resemblance of the former with the pKb of the histidine residues 
(pKb ~ 8.0) at the diiron core of sMMOH suggests that this benzimidazole diester ligand L3 
(Figure 5) is more biologically relevant to the sMMOH active site. To avoid ambiguity between 
the two N-donors of a benzimidazole ring in the future iron coordination chemistry, the meta-
nitrogen to the carboxylate has to be protected by a methyl group. Since I joined this project last 
summer, I have been involved in several aspects of this work: i) scaled-up synthesis of ligand 
L3; ii) UV-Vis titration experiments to determine the stoichiometry of L3, iron(II) salt, and an 
external carboxylate; iii) iron coordination chemistry of L3; iv) reactivity studies of the resulting 
diiron complexes with O2.  
 (a) (b) 
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Figure 5. Top. Comparison of the basicity of a benzoxazole nitrogen (left) and a benzimidazole 
nitrogen (right). Bottom. Because the pKb of benzimidazole is much lower than that of 
benzoxazole, L3, instead of L1, became our next target to tune the electron-donating ability of 






































Materials and Methods 
Unless otherwise noted, all reagents were obtained from TCI, Aldrich Chemical Co., and 
Alfa Aesar, and used as received. Column chromatography was performed using Silicycle 60 Å, 
ultrapure silica gel. All solvents were degassed by passage over two columns of activated 
alumina (Al2O3) under an argon atmosphere. Air-sensitive manipulations were carried out by 
standard schlenk techniques as well as in a MBraun nitrogen double glovebox. IR spectra were 
acquired on a ThermoNicolet Avatar 360 spectrophotometer with OMNIC software. 
Spectroscopic measurements were taken on a Cary 50 spectrophotometer using 6Q Spectrosil 
quartz cuvettes with 1 cm path lengths.  
X-ray Collection and Data Refinement (by Justin J. Wilson) 
 Samples for X-ray analysis were prepared by mounting single crystals in Paratone-N oil 
on a cryoloop and freezing them under a 110K KRYO-FLEX nitrogen cold stream. Data 
collection was performed by measuring diffraction intensities on a Bruker APEX CCD X-ray 
diffractometer with Mo-Kα radiation (λ = 0.71073 Å) at 100(2) K using the APEX2 software. 
Absorption corrections were performed using SADABS. The structures were solved by direct 
methods with SHELXS and refined by full-matrix least squares based on F
2
 using SHELXL.  
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Fe Mössbauer Spectroscopy (by Dr. Ulf-Peter Apfel) 
 Solid samples were suspended in Apiezon M grease and placed in nylon sample holder. 
Mössbauer data were acquired at 90 K on a MSI spectrometer (WEB Research Co.) with a 
57
Co 
source in a Rh matrix maintained at room temperature. The software reported isomer shift values 
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relative to metallic iron used for velocity calibration at room temperature. The WMOSS plot and 
fit program (WEB Research Co.) was used to fit the spectra with Lorentzian line shapes. 
Scaled-up Synthesis 
 When I started this project, the reaction conditions for the synthesis of the L3 ligand have 
been optimized by Dr. Li. Described below are the six reactions (highlighted in blue in Scheme 
3) that I ran for the scaled-up synthesis of L3. The rest were completed by Dr. Li. 
1,8-Dihydroxytriptycene dipropargyl ether (11) 
Solid 1,8-dihydroxyltriptycene (10) (14.0 g, 49.0 mmol) was combined with propargyl 
bromide (80% w/w in toluene, 7.28 g, 49.0 mmol, 1 equiv), and K2CO3 (20.3 g, 147 mmol, 3 
equiv) in 200 mL of acetone. The reaction mixture was refluxed, and over the course of 24 h, 
two additional portions of propargyl bromide (1 equiv per portion) were added at 12-h intervals. 
The reaction was quenched by cooling it to room temperature and then adding 200 mL of water. 
The organic phase was extracted with DCM (200 mL × 3). The combined organic extracts were 
washed with brine, dried over Na2SO4, passed through a filter paper, and concentrated under 
vacuum. The resulting material was purified by silica gel column chromatography (acetone: 
hexanes, 1:2) to obtain 16.5g of yellow solid (11) (93%). IR (KBr) 3446, 3293, 3284, 3059, 2959, 
2930, 2865, 2122, 1591, 1478, 1455, 1377, 1274, 1264, 1234, 1106, 1067, 1052, 788, 743, 688, 
667, 638 cm
-1
; Melting point: 214–216oC. 
Diacid (15) 
Dialdehyde (14) (400 mg, 1.02 mmol), 30% H2O2 (697 mg, 6.14 mmol, 6.0 equiv), and 
NaH2PO4·H2O (848 mg, 6.14 mmol, 6.0 equiv) were combined and suspended in a stirred 
mixture of acetone and H2O (200 mL and 60 mL respectively) at 10–15
o
C in a water bath. A 50 
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mL aqueous solution of NaClO2 (556 mg, 6.14 mmol, 6.0 equiv) was added dropwise to the 
stirred suspension via a dropping funnel over 2 h. The resulting suspension was stirred at room 
temperature overnight, and a clear light yellow solution was formed upon the complete 
consumption of the insoluble starting material, dialdehyde.  Acetone was evaporated under 
reduced pressure. Acidification of the resulting solution with 10% aqueous HCl to pH < 1 
afforded a yellow precipitate. The precipitate was filtrated, redissolved in THF (100 mL), and 
washed with water (10 mL) and brine (10 mL). The solution was dried over Na2SO4, filtered, and 
dried in vacuo to give 413 mg (95%) of diacid (15). IR (KBr) 3400, 3117, 3069, 2955, 2470, 
1908, 1710, 1631, 1564, 1459, 1406, 1333, 1289, 1185, 936, 853, 767, 751, 680, 645 cm
-1
; 
Melting point: 341–344oC. 
Methyl 3-chloro-2-nitrobenzoate (17) 
Solid 3-chloro-2-nitrobenzoic acid (16) (10.0 g, 50 mmol) was suspended in 250 mL 
Et2O under nitrogen gas. Into the stirred suspension was bubbled diazomethane, CH2N2, 
generated from slow addition of 10% NaOH to a 50 mL EtOH solution of Diazald until the TLC 
analysis indicated the complete consumption of the starting material 16. The product solution 
was purified by silica gel column chromatography (Acetone), and the resulting acetone eluate 
was concentrated by rotary evaporation to give 10.6 g (99%) of methyl 3-chloro-2-nitrobenzoate 
(17). IR (KBr) 3107, 3066, 2957, 2906, 2850, 1732, 1552, 1444, 1384, 1288, 1216, 1172, 978, 
853, 765, 718 cm
-1
; Melting point: 105–106 oC. 
3-(Methylamino)-2-nitrobenzoic acid  
A reaction mixture of methyl 3-(N-methylacetamido)-2-nitrobenzoate (18) (8.0 g, 31.7 
mmol) in 520 mL of 10% NaOH and 200 mL EtOH was allowed to stir at 80–85oC for 10 h. The 
solution was then cooled to 0
o
C before its pH was adjusted to 1.5–2.0 with concentrated HCl. 
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The organic phase, from extraction with EtOAc (4 × 150 mL), was washed with brine (30 mL), 
dried over Na2SO4, passed through a filter paper, and evaporated to dryness. The resulting red 
crude material (7.2 g) was employed in the next reaction step without further purification. IR 
(KBr) 3392, 2911, 1700, 1615, 1575, 1512, 1448, 1253, 1180, 1078, 1053, 799, 765 cm
-1
. 
Methyl 3-(methylamino)-2-nitrobenzoate (19) 
Slow addition of small aliquots of 10% aqueous NaOH via a syringe to an EtOH solution 
of Diazald produced diazomethane, which was bubbled into a suspension of a 1-g portion of the 
crude 3-(methylamino)-2-nitrobenzoic acid in 150 mL Et2O under a N2 environment. To convert 
all the starting material, the described 1-gram scale reaction was repeated seven times under the 
same conditions. Completion of each reaction was monitored by TLC.  Purification of the 
resulting red oil by silica gel column chromatography (Hexanes: EtOAc = 1:0, 10:1–4:1) gave 
6.0 g (90% in two steps) of methyl 3-(methylamino)-2-nitrobenzoate (19) as red oil. IR (KBr) 
3398, 3002, 2952, 2839, 1732, 1613, 1573, 1511, 1446, 1358, 1280, 1208, 1119, 1079, 1054, 
983, 853, 792, 754, 704, 547, 482 cm
-1
. 
Triptycene-based Bis(Benzimidazole) Diester Ligand L3 
 Solid diacid (15) (84.4 mg, 0.2 mmol) was suspended in 80 mL of anhydrous DCM under 
a N2 atmosphere. Pyridine (646 L, 8 mmol, 40 equiv) and thionyl chloride (584 L, 8 mmol, 40 
equiv) were added in order to the suspension. After stirring at room temperature for 60 h, the 
resulting solution was concentrated in vacuo, followed by high-vacuum drying for 8 h. The 
resulting solid was dissolved in 40 mL of anhydrous DCM.  The solution was treated with 
pyridine (646 L, 8 mmol, 40 equiv) before methyl 2-amino-3-(methylamino)benzoate (20) (72 
mg, 0.4 mmol, 2 equiv) was added. The resulting light brown reaction mixture was allowed to 
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stir at room temperature for 30 h. The crude solid 21, obtained upon rotary evaporation of all the 
volatiles, was used immediately in the subsequent reaction.  
The crude solid 21 was dissolved in 20 mL of HOAc. The reaction mixture was refluxed 
for 1 h, after which HOAc was removed. The residue, neutralized with Et3N on silica gel, was 
purified by flash column chromatography (DCM: EtOAc = 20:1–6:1) to give ligand L3 (68 mg, 
48% in 3 steps) as a pale yellow solid. IR (KBr) 3127, 3065, 2947, 2839, 1711, 1636, 1606, 
1449, 1384, 1294, 1254, 1207, 1118, 1061, 836, 752, 713, 680 cm
-1




 Inside a nitrogen box, a solution of Fe(OTf)2(MeCN)2 (OTf = OSO2CF3)  (36.9 mg, 
0.085 mmol, 2 equiv relative to L3) in 2 mL of MeCN was prepared, to which 2,6-di(p-
tolyl)benzoic acid (HO2CAr
Tol
) (12.8 mg, 0.042 mmol, 1.0 equiv. relative to L3) in THF (2 mL) 
and wet Et3N (11.7 μL, 0.085 mmol, 2.0 equiv. relative to L3) were added in order. The mixture 
was stirred at room temperature for 5 min. Addition of a solution of ligand L3 (30 mg, 0.042 
mmol) in DCM (2 mL) to the mixture instantaneously gave a red solution. The reaction 
suspension was stirred for 30 min, after which the solvent was removed under vacuum. 
Dissolving the resulting orange solids in DCM/MeOH (2 mL/0.5 mL) afforded a clear red 
solution. Impurities were removed by filtration with glass wool. By slowly diffusing Et2O into 
the purified solution of the compound over a few days, red needle-like crystals were obtained. 
The crystals were washed with Et2O twice, and upon drying under vacuum, 22.4 mg (34.8%) 
orange red crystals were yielded. IR (KBr) 3491, 3132, 3023, 2961, 2920, 1672, 1620, 1582, 








 Inside a nitrogen box, a solution of Fe(OTf)2(MeCN)2 (36.9 mg, 0.085 mmol, 2.0 equiv 
relative to L3) in 2 mL of MeCN was prepared and combined with a solution of NaO2CCPh3 
(sodium 2,2,2-triphenylacetate) (13.1 mg, 0.042 mmol, 1 equiv relative to L3) in THF (2 mL). 
The mixture was stirred at room temperature for 5 min. Slow addition of a solution of ligand L3 
(30 mg, 0.042 mmol) in DCM (2 mL) to the mixture instantaneously gave a red solution. The 
reaction suspension was stirred for 30 min, after which the solvent was removed under vacuum. 
Dissolving the resulting orange solids in DCM/MeOH (2 mL/0.5 mL) afforded a dark red 
solution. Impurities were removed by filtration with glass wool. By slowly diffusing Et2O into 
the purified solution of the compound over a few days, red needle-like crystals were obtained. 
The crystals were washed with Et2O twice, and upon drying under vacuum, 28 mg (43%) orange 
red crystals were yielded. IR (KBr) 3514, 3134, 3055, 2963, 2860, 1664, 1597, 1446, 1347, 
1305, 1238, 1161, 1030, 877, 754, 637 cm
-1
. 
UV-Vis Spectrophotometric Studies 
Inside an anaerobic box, the following four stock solutions were prepared: L3 (10 μM in 







mM, prepared by equimolar amounts of Ar
Tol
CO2H and Et3N in THF). 
Reaction of L3 with Fe(OTf)2 
Inside a nitrogen drybox, a sealed UV-Vis quartz cuvette holding 4 mL of L3 stock 
solution and a 50 μL airtight syringe loaded with Fe(OTf)2 stock solution were prepared and 
brought outside the box. Small aliquots of the anaerobic Fe(OTf)2 solution (5 μL, 0.5 equiv 
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relative to L3) were titrated to the sample in the cuvette, and their absorption spectra were 
recorded.  






 with a mixture of L3 and 2 equiv of Fe(OTf)2 
Inside a nitrogen box, a sealed UV-vis quartz cuvette that contained a mixture of 4 mL of 
L3 stock solution and a 20 μL portion of the Fe(OTf)2 solution (2 equiv relative to L3) was 
prepared and brought outside the box. To avoid air contact, a 50 μL airtight syringe loaded with a 






was inserted into a septum before being 







solution (5 μL, 1 equiv relative to L3) were titrated to the sample in the 
cuvette, and their absorption spectra were recorded.  







Inside a nitrogen box, a sealed UV-vis quartz cuvette that contained a mixture of 4 mL of 






solution (1 equiv 
relative to L3) was prepared and brought outside the box. To avoid air contact, a 50 μL airtight 
syringe loaded with the Fe(OTf)2 stock solution was inserted into a septum before being brought 






solution (5 μL, 0.5 equiv relative to L3) were titrated to the sample in the cuvette, and their 
absorption spectra were recorded.  
Reaction of [Fe2L3(μ-OH)(μ-O2CAr
Tol
)(OTf)2] with O2 
 A piece of [Fe2L3(μ-OH)(μ-O2CAr
Tol
)(OTf)2] red crystal was dissolved in 4 mL of 
degassed DCM in a nitrogen box. The solution was placed in a UV-vis dewar to maintain low 
temperature. The cell was capped with a septum, sealed with electronic tape, and taken out of the 
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glovebox. The DCM solution was cooled to -78 
o
C in a dry ice/acetone bath. Excess dry 
dioxygen (5 mL) was then bubbled into the cryogenic solution. Temperature of the solution was 
gradually raised to room temperature over the course of 10 h, and absorption spectra were 





































Scheme 3: Synthesis of benzimidazole diester ligand L3 
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A synthetic pathway to benzimidazole diester ligand L3 is shown in Scheme 3. Optimal 
reaction conditions had been established by Dr. Li when I started the project, and I mainly 
worked on the scaled-up synthesis of L3 to obtain materials for coordination studies. The 
reactions I have personally conducted are highlighted in blue. (I) Using propargyl bromide in 
acetone enabled allylation of 1,8-dihydroxytriptycene 1 to give 2 in 93% yield. (II) Oxidation of 
dialdehyde 5 to diacid 6 was achieved by using NaClO2 and 30% H2O2, buffered with NaH2PO4. 
Acidification with concentrated HCl gave a high yield of diacid. (III) The starting material 3-
chloro-2-nitro-benzoic acid 7 was reacted with diazomethane, produced from the reaction of 
diazald and sodium hydroxide in ethanol. Methyl 3-chloro-2-nitrobenzoate 8 was obtained as a 
product in 99% yield. (IV) The reaction of methyl 3-(N-methylacetamido)-2-nitrobenzoate 9 
with an excess amount of 10% NaOH in ethanol at 80
o
C gave hydrolysis of ester and amide 
group, resulting in 3-(methylamino)-2-nitrobenzoic acid. This crude product when reacted with 
diazomethane underwent esterification to give a 95% yield of methyl 3-(methylamino)-2-
nitrobenzoate 10 over two steps. (V) Using HATU as a reagent, amide coupling of the previously 
synthesized diacid intermediate 6 with diamine 11 gave 12. In this one-pot two-reaction step, 
cyclization of 12 was achieved by using acetic acid to give the desired L3. 
UV-Vis Spectrophotometric Titrations 
Upon the successful synthesis of the L3 ligand, our next step is to explore its 
coordination with iron as well as its ability to form an external carboxylate bridge. The 
coordination sphere of sMMOHred includes a diiron(II) core coordinated by two histidine N-
donor residues syn with respect to Fe-Fe vector and four carboxylate amino acid residues (two 
bridging and two terminal). To closely imitate the active site structure of the enzyme, the ligand 
L3 would need to bind with two iron(II) atoms and allow external carboxylate bridge(s) in the 
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system displayed intense optical features. To examine the ligand-metal-carboxylate interaction in 
the system that displayed prominent optical responses, a series of UV-vis spectrophotometric 
titrations were conducted.  
 
Figure 6. UV-vis absorption spectra acquired by titration of Fe(OTf)2 (0.5 equiv relative to L3 
per aliquot) to a DCM solution of L3 (10 μM). The apo L3 ligand is shown by the black dotted 
trace whereas the colored solid lines represent the spectra obtained upon the addition of iron(II) 
to L3. Maximal optical changes were observed at 386 nm, and a plot of the absorbance change at 
386 nm against the titrated amount of Fe(OTf)2 to L3 is illustrated in the top right corner.  
 
The experimental design was such that the metal-to-ligand stoichiometry in the absence 
of ancillary carboxylates was first explored.  Each set of titration was repeated three times under 
the same conditions to obtain an averaged trend. As shown in Figure 6, free L3 ligand displayed 
a strong absorption at 345 nm.  Successive addition of Fe(OTf)2 to the L3 solution resulted in a 
gradual decrease in the intensity of the 345 nm band. When > 1 equiv of iron(II) was present in 
the solution, the band at 345 nm shifted hypsochromically to 351 nm, concomitant with an 
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increased absorption at 365 and 386 nm. A plot of the optical changes at 386 nm, characteristic 
of an Fe-O(H)-Fe species, suggests that L3 is capable of binding with at least two iron atoms 
although determination of the exact metal-to-ligand ratio was prevented by the large fluctuation 
of the data, regardless of multiple repetitions (Figure 6). The presence of an isosbestic point at 
308 nm demonstrates a conversion from A to B.  







 (terphenylcarboxylate for simplicity) were titrated to a premixed solution 
containing 2 equiv of Fe(OTf)2  and 1 equiv of L3. This 2:1 metal-to-ligand ratio was chosen to 
construct dinuclear complexes as in the enzyme. In Figure 7a is shown a plot of the optical 






 to the solution. Absorption at 
386 nm grew upon the addition of terphenylcarboxylate and reached an optimal value at 1 equiv 
of carboxylate. The presence of excess carboxylate resulted in a dramatic decrease in the band at 
386 nm as well as a spectral growth at 345 nm, a characteristic absorption of the free L3 ligand. 
This behavior may therefore be indicative of the labile nature of the resulting diiron complex 
system with an external carboxylate. An excess amount of bulky carboxylates seems to disrupt 
the coordination sphere by extracting iron(II) from the complex, forming iron carboxylates and 







 complex is formed favorably in the solution. 







equiv relative to L3 based on the previous titration) was prepared, to which various aliquots of 
Fe(OTf)2 were added. A plot of the absorbance changes versus the titrated amount of iron(II) is 
given in Figure 7c. The spectral band at 386 nm gradually increased and reached a maximum at 
2.0 equiv of the Fe(II) solution. A slight decrease in the absorption at 386 nm in the 
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Figure 7: Plots of the spectral change at 386 nm (at which maximum absorbance change occurs) against the titrated amount of a) Fe(OTf)2 to 






 (1 equiv rel to L3); b) Fe(OTf)2 to a solution containing L3 (10 M in 






 to a solution containing L3 (10 M in DCM) and Fe(OTf)2 (2 equiv rel to 
L3); d) NaO2CCPh3 to a solution containing L3 (10 M in DCM) and Fe(OTf)2 (2 equiv rel to L3). The error bars represent the standard 








































































presence of excess iron(II) could be a result of the free Fe(OTf)2 extruding carboxylate from the 
diiron complex system.  
Interaction of L3 with Fe(OTf)2 and a different external carboxylate with similar steric 
effects as terphenylcarboxylate, Ph3CCO2Na (triphenyacetate for simplicity), was also examined 
with similar UV-Vis spectrophotometric studies. Comparable results were obtained, suggesting 
the 1:2:1 stoichiometry among the ligand, iron(II), and triphenylacetate. Based on these data, L3 
can support a diiron structure with an external carboxylate. The effect of a structural difference 






on the coordination chemistry appears to be minimal. 
Assembly and Characterization of Diiron(II) Complexes 
X-ray Diffraction Studies 
To examine the structures of the diiron complexes derived from L3, single red crystals 
were grown by slow vapor diffusion of diethyl ether into a DCM/MeOH solution of the 1:2:1  






 or Ph3CCO2Na). 
Single crystals suitable for X-ray diffraction analysis were obtained from both carboxylates, and 
their molecular formula are [Fe2L3(-OH)(-O2CR)(OTf)2], where R = Ar
Tol
 (22, Figure 8, 
Table 2) or Ph3C (23, Figure 9, Table 2). By comparison of 22 and 23, the two structures have 
similar five-coordinated metal coordination geometries. In addition to a bridging hydroxide and a 
bridging carboxylate between the two iron centers, each iron unit is coordinated by a terminal 
triflate (OTf) and chelated by a nitrogen atom and an ester carbonyl oxygen atom from one 
benzimidazole arm of L3 ligand. Although the triflate ligands from iron(II) salt were expected to 
be replaced by external carboxylates, they remained coordinated to the iron centers in both 
complexes.  This observation could be partly due to the large size of both carboxylates, which 
could not fit into the position of the terminal triflate ligands. One of these triflate ligands 
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interacts with the bridging hydroxide via hydrogen bonding. As shown in Table 3, bond metrics 
in both complexes are analogous. The Fe—Fe distances in both complexes (3.489 Å in 22 and 
3.444 Å in 23) resemble the Fe—Fe distance in sMMOH (3.43 Å).46 The average Fe—O 
distances (carboxylate) in 22 and 23 are 2.071 Å and 2.068 Å respectively. The average distances 
between iron and ester carbonyl oxygen atoms are also similar (2.107 Å in 22 and 2.131 Å in 
23).  The Fe—O distances of the triflate ligands vary from 2.184 and 2.284 Å, which are longer 
than other Fe—O distances in the structures.   
The effect of employing a more basic benzimidazole ligand L3 rather than L1 was 
explored by comparing the structures of 22 and 23 with a previously reported X-ray structure of 
a diiron complex derived from L1 [Fe2L1(-OH)(-O2CAr
Tol
)(OTf)2] (24, Figure 4a). Table 3 
lists relevant parameters in their respective structures. Although the nitrogen donors in 22 and 23 
are much more basic than those in 24, the two structures show similarity in Fe—N distances as 
well as other Fe—L distances. Interestingly, however, there was a significant change in the 
Fe∙∙∙O (benzofuran) distances between complexes derived from L1 and L3. The average Fe∙∙∙O 
(benzofuran) distances in 22 and 23 are 2.69 Å and 2.74 Å, respectively (Table 3) whereas the 
distance in 24 is much longer (3.02 Å, Table 3).  These shorter distances in 22 and 23 could be 
an outcome of intrinsic different electronic properties of benzimidazole-based ligands. In 
addition, the coordination geometries of the three complexes 22-24 were compared based on the 
parameter, τ, described in Table 3. This parameter (eq 2) describes the distortion of a five-






In 22, the τ values of the two irons are 0.05 and 0.08 (both close to 0), which correspond to a 
nearly perfect square-pyramidal coordination geometry. On the other hand, the τ values for 23 
are 0.20 and 0.30, and those for 24 are 0.30 and 0.41. These values indicate that the iron atoms in 
these structures attain a higher degree of distortion towards trigonal-bipyramidal geometries.  
 
  
               
 
Figure 8. X-ray crystal structure of [Fe2L3(-OH)(-O2CAr
Tol
)(OTf)2] 22 with 50% probability 
thermal ellipsoid and a partial numbering scheme. Hydrogen atoms and solvent molecules are 
omitted for clarity. Iron, green; carbon, gray; oxygen, red; nitrogen, blue; sulfur, yellow; 
fluorine, yellow green. Selected bond lengths (Å) and angles (deg): Fe1-N1, 2.084(6); Fe2-N2, 
2.100(6); Fe1-O5, 2.091(6); Fe2-O7, 2.122(5); Fe1-O10, 2.074(5); Fe2-O11, 2.068(5); Fe1-O9, 
1.943(5); Fe2-O9, 1.962(5); Fe1-O12, 2.284(3); Fe2-O15, 2.212(6); Fe1-O9-Fe2, 126.5(3); O9-
Fe1-O10, 97.9(2); O9-Fe2-O11, 95.0(2); O9-Fe1-N1, 167.3(3); O9-Fe2-N2, 168.1(2); O10-Fe1-






       
 
Figure 9. X-ray crystal structure of [Fe2L3(-OH)(-O2CCPh3)(OTf)2] 23 with 50% probability 
thermal ellipsoid and a partial numbering scheme. Hydrogen atoms and solvent molecules are 
omitted for clarity. Iron, green; carbon, gray; oxygen, red; nitrogen, blue; sulfur, yellow; 
fluorine, yellow green. Selected bond lengths (Å) and angles (deg): Fe1-N1, 2.106(4); Fe2-N2, 
2.113(4); Fe1-O5, 2.133(4); Fe2-O7, 2.128(4); Fe1-O10, 2.073(4); Fe2-O11, 2.062(4); Fe1-O9, 
1.961(4); Fe2-O9, 1.953(4); Fe1-O12, 2.230(4); Fe2-O15, 2.184(4); Fe1-O9-Fe2, 123.3(2); O9-
Fe1-O10, 97.04(15); O9-Fe2-O11, 93.23(15); O9-Fe1-N1, 158.25(17); O9-Fe2-N2, 177.68(17); 





Table 2.  Crystal data and structure refinement for complexes 22 and 23. 
 
Identification code   22(CH2Cl2)(Et2O)   23(CH2Cl2) 
Empirical formula   C72H60Cl2F6Fe2N4O16S2  C67H48Cl2F6Fe2N4O15S2 
Formula weight   1597.96    1509.81 
Temperature    100(2) K    100(2) K 
Wavelength    0.71073 Å    0.71073 Å 
Crystal system   Monoclinic    Orthorhombic 
Space group    P2(1)/c    P2(1)2(1)2(1) 
Unit cell dimensions   a = 19.9244(14)°   a = 16.0657(9) Å 
b = 20.6794(15)°   b = 19.7408(11) Å 
c = 19.7602(14)°   c = 19.9989(11) Å 
 = 118.8530(10)° 
Volume    7131.0(9) Å
3
    6342.6(6) Å
3
 
Z     4     4 
Density (calculated)   1.488 g/cm
3
    1.581 g/cm
3
 
Absorption coefficient  0.627 mm
-1
    0.698 mm
-1
 
F(000)     3280     3080 
Crystal size    0.40 x 0.10 x 0.10 mm
3
  0.20 x 0.14 x 0.06 mm
3
  
Theta range for data collection  1.55 to 23.38°    1.63 to 25.14° 
Index ranges                -22<=h<=22    -18<=h<=19 
-23<=k<=23    -23<=k<=23 
-22<=l<=22      -23<=l<=23 
Reflections collected   97291     101906 
Independent reflections  10347 [R(int) = 0.0640]  11325 [R(int) = 0.1103] 
Completeness to theta=24.83° 99.6 %     99.8 % 
Absorption correction   Semi-empirical from equivalents Semi-empirical from equivalents 
Max. and min. transmission  0.9400 and 0.7876   0.9593 and 0.8729 
Refinement method   Full-matrix least-squares on F
2
 Full-matrix least-squares on F
2
 
Data / restraints / parameters  10347 / 244 / 946   11325 / 56 / 913 
Goodness-of-fit on F
2
   1.054     1.047 
Final R indices [I>2(I)]  R1 = 0.0917, wR2 = 0.2417  R1 = 0.0569, wR2 = 0.1190 
R indices (all data)   R1 = 0.1204, wR2 = 0.2682  R1 = 0.0860, wR2 = 0.1314 
Largest diff. peak and hole  4.375 and -0.698 e.Å
-3a





The residual electron density and hole are in the region of disordered/partially occupied solvent molecules.  
Table 3. Selected distances, angles, and geometric parameter () in complexes 22-24. 
 22 23 24 
Fe1···Fe2 3.487 3.444 3.448 
N1···N2 7.335 7.233 7.320 
Fe1···O1 2.690 2.860 3.060 
Fe2···O2 2.695 2.610 2.987 
O1···O2 5.135 5.169 5.076 
Fe–OH–Fe 126.5 123.3 124.3 
 (Fe1) 0.05 0.20 0.30 




 The zero-field 
57
Fe Mössbauer spectra of the complexes 22 and 23 were acquired at 77 K 
to examine the oxidation state of iron atoms in the complexes. As shown in Figure 10, the 
Mössbauer spectrum of 22 shows a single quadrupole doublet, indicating that the two iron units 
in the complex are chemically equivalent. This complex has an isomer shift () value of 1.218 
mms-1 and a quadrupole splitting (EQ) is 1.960 mms
-1
 (Table 4). In addition, the complex 23 
shows an isomer shift () value of 1.224 mms-1 and a quadrupole splitting (EQ) is 2.064 mms
-1
 
(Table 4). These parameters are characteristic of our desired high spin diiron(II) complexes. 
Mössbauer data thus suggested that we have obtained diiron(II) complexes derived from L3.  
Table 4. Mössbauer fits for complexes 22 and 23. 
 22 23 
isomer shift () (mms-1) 1.218 1.224 
quadruple splitting (EQ) (mms
-1
) 1.960 2.064 
 
     
Figure 10. The zero-field 
57






 To obtain the IR spectra of the diiron complexes 22 and 23, the KBr pallets containing 
the samples were prepared in a nitrogen glove box to avoid air contact. The obtained spectra 
were compared with the spectrum of the free L3 ligand. As shown in Figures 11 and 12, the 
carbonyl stretch shown in L3 (1711 cm
-1





in 22 and 1664 cm
-1
 (magneta) in 23. This frequency shift suggests 
that the carbonyl oxygen atoms from the L3 esters are coordinated to the iron centers in the 
complexes. 
       
Figure 11. Overlaid IR spectra of the free L3 ligand (red) and the diiron complex [Fe2L3(-
OH)(-O2CAr
Tol
)(OTf)2] (22, blue). The carbonyl stretch in L3 (1711 cm
-1
) is shifted to a lower 
wavenumber (1672 cm
-1
) in 22. 
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Figure 12. Overlaid IR spectra of the apo L3 ligand (red) and the diiron complex of [Fe2L3(-
OH)(-O2CCPh3)(OTf)2] (23, magneta). The carbonyl stretch in L3 (1711 cm
-1
) is shifted to a 
lower wavenumber (1664 cm
-1




)(OTf)2] (22) with O2 
With the diiron(II) complex 22  in hand, we were interested in studying its reactivity with 
molecular oxygen. Figure 13 shows the absorption spectra of the DCM solution of 22 acquired at 
room temperature, both before and after the introduction of O2. A comparison of the two spectra 
shows a change in the optical profile after O2 exposure of 22 (Figure 13). This new spectrum 
looks very similar to that obtained from the apo L3 ligand (Figure 6, black line), suggesting that 
the diiron complex of 22 was decomposed to the free ligand upon the O2 reaction at room 
temperature.  
 Although reaction of 22 with molecular oxygen at rt led to decomposition of the diiron 
complex, an oxygenated species could form at lower temperature. To explore this possibility, a 
40 
 
solution of 22 in DCM was prepared in a dewar to maintain low temperature. As shown in Figure 
14, absorption spectra were taken at various temperatures, from -78°C to rt. Ideally, we expected 
to see a peroxo intermediate, as in the sMMOH catalytic cycle, which corresponds to a broad 
absorption band from 600- 800 nm. Unfortunately, no spectral change was observed at -78°C 
after 22 was exposed to dry O2. There was also no optical change when the temperature was 
gradually raised till it reached rt when the diiron complex decayed to a free L3 ligand. 
                 
Figure 13. Absorption spectra of 22 acquired at rt, both before and after the introduction of 
molecular oxygen  
      





In our attempt to design a dinucleating ligand platform to afford diiron complexes that 
mimic the active site structure of sMMOH, our L3 ligand system has shown promise as a pre-
organized precursor. Its interaction with iron(II) salt and an external carboxylate was examined 
by UV-vis spectroscopic titration experiments, which revealed the ideal stoichiometry of L3, 
Fe(II), and carboxylate to be 1:2:1. Single crystals of the diiron complexes derived from L3 
could be grown in a few days, and X-ray single crystal analysis of the structures 22 and 23 
showed similarities between their coordination cores and the active sites of sMMOH. The diiron 
cores in the model compounds have an oxygen-rich environment with syn N-donor characters. 
This ligand platform allows the bridging of a bulky external carboxylate between the two metal 
centers. When compared with the similar diiron complex derived from the previously reported 
benzoxazole ligand L1, complexes 22 and 23 have much shorter Fe∙∙∙O (benzofuran) distances. 
The coordination of carbonyl ester oxygen atoms to the iron centers is confirmed by the shift of 
carbonyl stretch in L3 to a lower frequency in the complexes 22 and 23. In addition, Mössbauer 
spectroscopy has revealed the presence of high-spin iron(II) units in 22. Upon oxygenation at rt, 
the complex 22 was found to decay to a free L3 ligand. Although the desired peroxo species was 
not observed when 22 was reacted with O2 at -78°C, information from the coordination 
chemistry of L3 has led to ongoing work with an emphasis on modifying the L3 system to its 
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